Merck & Co Inc (NYSE:MRK)
$ 130.06 -0.17 (-0.13%) Market Cap: 329.42 Bil Enterprise Value: 358.02 Bil PE Ratio: 144.51 PB Ratio: 8.16 GF Score: 88/100

Merck & Co Inc at CECP CEO Investor Forum (Virtual) Transcript

Jun 07, 2021 / 02:00PM GMT
Release Date Price: $72.8 (-1.77%)
Meg Tirrell

(technical difficulty)

Chairman and CEO of Merck. He's been there, of course, since 1992 in this role since 2011. Of course, in February, which was the last time that Ken and I got to speak, they announced his retirement as CEO, although he'll remain Executive Chairman for some period of time. Of course, as CEO of Merck, Ken has overseen the rise of KEYTRUDA. At the beginning of his tenure as CEO, he told me there was a pressure on the industry to cut research and development. That was a pressure that he resisted.

I'm going to hand it over to Ken Frazier now for his presentation. And I also encourage everybody to put your questions in the Q&A tab, and we'll get to those after the presentation. Ken, over to you.

Kenneth C. Frazier
Merck & Co., Inc. - CEO & Chairman

Okay. Good morning all, and thank you, Meg, for that introduction. I also want to thank the Chief Executives for Corporate Purpose, along with the Biopharma Sustainability Roundtable, for hosting this forum today.

Just 3 years ago, I joined many of you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot